Clinical research - Press Releases

Date	Title	Company
07-Dec-2020	Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets	Kaia Health
07-Dec-2020	Biophytis –Upcoming Potential Value Generating Milestones	Biophytis SA
06-Dec-2020	MAGROLIMAB DEMONSTRATES CLINICAL RESPONSES IN ONGOING PHASE 1B TRIAL OF PREVIOUSLY UNTREATED ACUTE MYELOID LEUKAEMIA PATIENTS	Gilead Sciences, Inc.
06-Dec-2020	NEW FOUR-YEAR DATA SHOW LONG-TERM SURVIVAL IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA TREATED WITH YESCARTA® (AXICABTAGENE CILOLEUCEL) IN ZUMA-1 TRIAL	Kite, A Gilead Company
06-Dec-2020	YESCARTA® (AXICABTAGENE CILOLEUCEL) IS FIRST CAR T CELL THERAPY TO DEMONSTRATE HIGH RESPONSE RATES AND DURABLE CLINICAL BENEFIT IN A PIVOTAL INDOLENT NON-HODGKIN LYMPHOMA STUDY	Kite, A Gilead Company
05-Dec-2020	Trending Now: AI Smart Baby Monitors Market Global Industry Size, Growth, Segments, Revenue, Manufacturers & Forecast Research Report	Alexa Reports
02-Dec-2020	UK biotech company ILC Therapeutics announces first international investment	ILC Therapeutics
02-Dec-2020	Kallik becomes first artwork and labelling management software company to offer customers the security of Amazon Web Services	Kallik
02-Dec-2020	John Bell & Croyden expands same day coronavirus testing service with launch of new 15-minute point-of-care test	John Bell & Croyden
02-Dec-2020	New data from Cell and Gene Therapy Catapult report shows move towards commercialisation and 48% increase in GMP manufacturing space despite COVID-19 pandemic	The Cell and Gene Therapy Catapult
02-Dec-2020	Helsinn and Kyowa Kirin Asia Pacific sign exclusive license and distribution agreement to strengthen their presence in Asia Pacific’s rare disease therapy area	Helsinn Group
02-Dec-2020	Sosei Heptares and Biohaven Enter Global Collaboration and License Agreement to Advance Novel Small-Molecule CGRP Antagonist Portfolio	Sosei Group Corporation
02-Dec-2020	Resolution Therapeutics Announces a £26.6m Series A Financing from Syncona Ltd	Resolution Therapeutics Limited
02-Dec-2020	BioInnovation Institute takes in new cohort of promising early-stage innovations	BioInnovation Institute (BII),
02-Dec-2020	atbtherapeutics initiates agreement with iBio CDMO to manufacture game-changer atbodies to better treat cancer	atbtherapeutics
02-Dec-2020	Boehringer Ingelheim: Digital Lab BI X Facilitates Global Partnerships	Boehringer Ingelheim
02-Dec-2020	iRhythm Technologies Receives Positive National Guidance in First of its Kind Digital Health Pilot with National Institute for Health and Care Excellence	iRhythm Technologies, Inc.
02-Dec-2020	DuPont Brings Science-backed Quality and Innovation to Asia’s Pharmaceutical Industry at CPhI China 2020	DuPont
02-Dec-2020	ViiV Healthcare and the Medicines Patent Pool expand access to dolutegravir-based regimens for people living with HIV in Azerbaijan, Belarus, Kazakhstan and Malaysia with innovative new licensing agreement	ViiV Healthcare
02-Dec-2020	uMed raises £3.7m in venture capital funding to help healthcare providers participate in more clinical studies	uMed